Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    

IMMUNOCELLULAR THERAPEUTICS LTD
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCalendarCompanyFinancialsRevisions 
Financials (USD)
More Financials
Company
ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers.The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma... 
More about the company
Latest news on IMMUNOCELLULAR THERAPEUTIC
05/15IMMUNOCELLULAR THERAPEUTICS, LTD. : Results of Operations and Financial Conditio..
AQ
05/14IMMUNOCELLULAR THERAPEUTICS : Announces First Quarter 2018 Financial Results
PU
04/12IMMUNOCELLULAR THERAPEUTICS : Announces Achievement of Next Key Milestone in Ste..
PU
03/14IMMUNOCELLULAR THERAPEUTICS : Management's Discussion and Analysis of Financial ..
AQ
03/13IMMUNOCELLULAR THERAPEUTICS, LTD. : Results of Operations and Financial Conditio..
AQ
03/13IMMUNOCELLULAR THERAPEUTICS LTD : ImmunoCellular Therapeutics, Ltd. to Host Earn..
AC
03/07IMMUNOCELLULAR THERAPEUTICS LTD : Today’s Research Reports on Trending Tickers: ..
AC
02/28GLOBAL IMAGE-GUIDED SURGERY DEVICES : Comprehensive Research on Image-Guided Su..
AQ
02/27GLOBAL AIR CLEANING SYSTEM MARKET TO : Latest Research Report on Air Cleaning Sy..
AQ
02/22IMMUNOCELLULAR THERAPEUTICS : Announces Review of Strategic Alternatives
PU
More news
Sector news : Biotechnology & Medical Research - NEC
05/25The Heated Quest for Opioid Alternatives -2-
DJ
05/25The Heated Quest for Opioid Alternatives
DJ
05/18GLAXOSMITHKLINE : Regulators flag possible birth defect link to GSK's HIV drug
RE
05/11Trump's Plan to Cut Drug Prices Leaves Industry Relieved
DJ
05/09Drugmaker GSK rings in more change as CFO heads for exit in 2019
RE
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
2016ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q3 2016 Results - Ea.. 
2016ImmunoCellular Therapeutics EPS in-line 
2016ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q2 2016 Results - Ea.. 
2016ImmunoCellular Therapeutics beats by $0.01 
2016ImmunoCellular's late-stage study of lead product candidate in glioblastoma c.. 
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
EPS Revisions
Managers
NameTitle
Anthony J. Gringeri President, Chief Executive Officer & Director
Gary S. Titus Chairman & Secretary
David E. Fractor Chief Financial & Accounting Officer
Steven J. Swanson Senior Vice President-Research
John S. Yu Director
Sector and Competitors
1st jan.Capitalization (M$)
IMMUNOCELLULAR THERAPEUTICS LTD11
CELLTRION, INC.--.--%32 036
IQVIA HOLDINGS INC4.64%20 818
LONZA GROUP1.63%20 226
INCYTE CORPORATION-29.71%14 505
NEKTAR THERAPEUTICS42.83%13 705